These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11980769)

  • 1. The effect of a change in the dose of trimegestone on the pattern of bleeding in estrogen-treated post-menopausal women: 6 month extension of a dose-ranging study.
    Wahab M; Thompson J; Whitehead M; Al-Azzawi F
    Hum Reprod; 2002 May; 17(5):1386-90. PubMed ID: 11980769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability and patterns of uterine bleeding in sequential trimegestone-based hormone replacement therapy: a dose-ranging study.
    Al-Azzawi F; Wahab M; Thompson J; Whitehead M; Thompson W
    Hum Reprod; 1999 Mar; 14(3):636-41. PubMed ID: 10221688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of submucous fibroids on the dose-dependent modulation of uterine bleeding by trimegestone in postmenopausal women treated with hormone replacement therapy.
    Wahab M; Thompson J; Al-Azzawi F
    BJOG; 2000 Mar; 107(3):329-34. PubMed ID: 10740328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
    al-Azzawi F; Wahab M; Thompson J; Pornel B; Hirvonen E; Ylikorkala O; van der Mooren MJ; Dillon J; Magaril C
    Climacteric; 2001 Dec; 4(4):343-54. PubMed ID: 11770191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of endometrial leukocytes and their proliferation markers in trimegestone-treated postmenopausal women compared to the endometrium of the natural cycle: a dose-ranging study.
    Wahab M; Thompson J; Al-Azzawi F
    Hum Reprod; 1999 May; 14(5):1201-6. PubMed ID: 10325261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimegestone: expanding therapeutic choices for the treatment of the menopause.
    Wahab M; Al-Azzawi F
    Expert Opin Investig Drugs; 2001 Sep; 10(9):1737-44. PubMed ID: 11772282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women.
    Koninckx PR; Spielmann D
    Gynecol Endocrinol; 2005 Aug; 21(2):82-9. PubMed ID: 16294460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial effects of three doses of trimegestone, a new orally active progestogen, on the postmenopausal endometrium.
    Ross D; Godfree V; Cooper A; Pryse-Davies J; Whitehead MI
    Maturitas; 1997 Sep; 28(1):83-8. PubMed ID: 9391999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone.
    Hellgren M; Conard J; Norris L; Kluft C
    Maturitas; 2009 Mar; 62(3):287-93. PubMed ID: 19268506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial histomorphometry of trimegestone-based sequential hormone replacement therapy: a weighted comparison with the endometrium of the natural cycle.
    Wahab M; Thompson J; Hamid B; Deen S; Al-Azzawi F
    Hum Reprod; 1999 Oct; 14(10):2609-18. PubMed ID: 10527996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone.
    Norris LA; Brosnan J; Bonnar J; Conard J; Kluft C; Hellgren M
    Thromb Haemost; 2008 Aug; 100(2):253-60. PubMed ID: 18690345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone.
    Ferenczy A; Gelfand MM
    Maturitas; 1997 Apr; 26(3):219-26. PubMed ID: 9147354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HRT in post-menopausal women: endometrial histology and bleeding patterns].
    Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM
    Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of different cyclical sequential progestins on endometrial vascularity in postmenopausal women compared with the natural cycle: a morphometric analysis.
    Wahab M; Thompson J; Al-Azzawi F
    Hum Reprod; 2000 Oct; 15(10):2075-81. PubMed ID: 11006176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 17 beta-estradiol and trimegestone alone, and in combination, on the bone and uterus of ovariectomized rats.
    Lepescheux L; Secchi J; Gaillard-Kelly M; Miller P
    Gynecol Endocrinol; 2001 Aug; 15(4):312-20. PubMed ID: 11560106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with trimegestone as a new progestin in HRT.
    Grubb G; Spielmann D; Pickar J; Constantine G
    Steroids; 2003 Nov; 68(10-13):921-6. PubMed ID: 14667984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharma-Clinics. Medication of the month. Totelle Cycle: new sequential estrogen/progesterone regimen for hormone replacement therapy in menopause].
    Gaspard U
    Rev Med Liege; 2002 Jun; 57(6):408-12. PubMed ID: 12180037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unscheduled bleeding in continuous combined hormone therapy users.
    Hickey M; Ameratunga D; Marino JL
    Maturitas; 2011 Dec; 70(4):400-3. PubMed ID: 22030385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
    Gynecol Endocrinol; 2002 Apr; 16(2):155-62. PubMed ID: 12012627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy? UK Continuous Combined HRT Study Investigators.
    Sturdee DW; Barlow DH; Ulrich LG; Wells M; Gydesen H; Campbell M; O'Brien K; Vessey M
    Lancet; 1994 Oct; 344(8928):979-82. PubMed ID: 7934429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.